Showing results (391-400 of 513) with videos related to

Sort By:
Pageof 52
Journal of Cancer Research and Clinical Oncology|May 6, 2014
Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosisYu Jung Kim, Su-Jung Kim, June Koo Lee, et al.
Cancer Immunology, Immunotherapy : CII|November 24, 2020
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancyChanghee Park, Kyeonghun Jeong, Joon-Hyeong Park, et al.
Molecular Cancer|May 3, 2024
Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implicationsJoo Kyung Park, Hyoung-Oh Jeong, Hyemin Kim, et al.
Japanese Journal of Clinical Oncology|October 7, 2004
Primary pulmonary non-Hodgkin's lymphomaJung Han Kim, Se-Hoon Lee, Jinny Park, et al.
Japanese Journal of Clinical Oncology|November 26, 2010
Increasing nodal ratio is a poor prognostic factor for survival in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: a retrospective studyJin-Soo Kim, Min-A Kim, Do-Youn Oh, et al.
Journal of Korean Medical Science|June 17, 2006
Pulmonary complications after hematopoietic stem cell transplantationDo Hyoung Lim, Jeeyun Lee, Hong Ghi Lee, et al.
Cancer Research and Treatment|April 7, 2010
Three cases of synchronous solid tumor and multiple myelomaSang Hoon Ji, Joon Oh Park, Jeeyun Lee, et al.
The New England Journal of Medicine|June 5, 2023
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung CancerHeather Wakelee, Moishe Liberman, Terufumi Kato, et al.
Iscience|November 7, 2022
Cellular plasticity and immune microenvironment of malignant pleural effusion are associated with EGFR-TKI resistance in non-small-cell lung carcinomaHyoung-Oh Jeong, Hayoon Lee, Hyemin Kim, et al.
BMC Cancer|November 3, 2007
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancerBhumsuk Keam, Seock-Ah Im, Hee-Jun Kim, et al.
Pageof 52